(XPEV) Xpeng - NYSE
Sector: Consumer Cyclical | Industry: Auto Manufacturers | Exchange: NYSE (USA) | Market Cap: 12.625m USD | Total Return: -32.7% in 12m
Avg Turnover: 107M
Qual. Beats: 0
Rev. Trend: 98.6%
Qual. Beats: 0
Warnings
Interest Coverage Ratio -11.3 is critical
Altman Z'' -0.88 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
XPeng Inc. (XPEV) is a Guangzhou-based manufacturer of smart electric vehicles (EVs) operating primarily in the Chinese market. The company’s portfolio includes a diverse range of sedans, SUVs, and multi-purpose vehicles (MPVs), such as the P7 series, G9, G6, and the X9 seven-seater. Beyond vehicle manufacturing, XPeng develops proprietary technology including the XOS Tianji operating system and the SEPA 2.0 platform architecture.
The company operates within the highly competitive Chinese NEV (New Energy Vehicle) sector, where vertical integration of software and hardware is a key differentiator. XPeng’s business model extends to post-sale revenue streams, including supercharging networks, technical research, and automotive financing services. The Chinese EV market remains the worlds largest by volume, driven by aggressive infrastructure expansion and government subsidies for high-tech manufacturing.
For a deeper look into the companys financial health and valuation metrics, consider reviewing the latest data on ValueRay. XPeng continues to focus on autonomous driving capabilities and powertrain efficiency to maintain its position against both domestic startups and established global automakers.
- MONA M03 and P7+ delivery volume determines near-term revenue growth trajectory
- Volkswagen strategic partnership and technology service fees improve long-term gross margins
- Advanced driver-assistance system adoption rates differentiate brand value in competitive market
- European Union trade tariffs and geopolitical tensions impact international expansion profitability
- Chinese consumer sentiment and EV price wars pressure domestic vehicle delivery margins
| Net Income: -2.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 9.89 > 1.0 |
| NWC/Revenue: 9.93% < 20% (prev 18.12%; Δ -8.19% < -1%) |
| CFO/TA 0.08 > 3% & CFO 8.26b > Net Income -2.25b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (477.6m) vs 12m ago -49.49% < -2% |
| Gross Margin: 19.87% > 18% (prev 14.88%; Δ 4.98% > 0.5%) |
| Asset Turnover: 77.70% > 50% (prev 56.39%; Δ 21.31% > 0%) |
| Interest Coverage Ratio: -11.34 > 6 (EBIT TTM -4.69b / Interest Expense TTM 413.9m) |
| A: 0.07 (Total Current Assets 60.4b - Total Current Liabilities 53.1b) / Total Assets 100b |
| B: -0.44 (Retained Earnings -44.4b / Total Assets 100b) |
| C: -0.05 (EBIT TTM -4.69b / Avg Total Assets 94.7b) |
| D: 0.39 (Book Value of Equity 28.4b / Total Liabilities 72.1b) |
| Altman-Z'' = -0.88 = CCC |
| DSRI: 0.65 (Receivables 4.40b/4.62b, Revenue 73.6b/50.1b) |
| GMI: 0.75 (GM 14.88% / 19.87%) |
| AQI: 0.88 (AQ_t 0.21 / AQ_t-1 0.24) |
| SGI: 1.47 (Revenue 73.6b / 50.1b) |
| TATA: -0.10 (NI -2.25b - CFO 8.26b) / TA 100b) |
| Beneish M = -3.29 (Cap -4..+1) = AA |
As of June 27, 2026, the stock is trading at USD 12.09 with a total of 8,436,172 shares traded. Over the past week, the price has changed by -8.48%, over one month by -26.95%, over three months by -31.35% and over the past year by -32.65%.
Current recommended Stop Loss: 11.30 (which is 6.5% or 1.3 ATR below the current price).
Xpeng has received a consensus analysts rating of 4.21. Therefore, it is recommended to buy XPEV.
- StrongBuy: 14
- Buy: 7
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 22.7 | 87.3% |
Market Cap CNY = 85.8b (12.6b USD * 6.7982 USD.CNY)
P/E Forward = 69.9301
P/S = 0.1707
P/B = 2.9979
Revenue TTM = 73.6b CNY
EBIT TTM = -4.69b CNY
EBITDA TTM = -1.70b CNY
Long Term Debt = 9.00b CNY (from longTermDebt, last quarter)
Short Term Debt = 26.1b CNY (from shortTermDebt, last quarter)
Debt = 48.5b CNY (from shortLongTermDebtTotal, last quarter) + Leases 7.12b
Net Debt = 11.4b CNY (calculated: Debt 48.5b - CCE 37.1b)
Enterprise Value = 97.2b CNY (85.8b + Debt 48.5b - CCE 37.1b)
Interest Coverage Ratio = -11.34 (Ebit TTM -4.69b / Interest Expense TTM 413.9m)
EV/FCF = 19.79x (Enterprise Value 97.2b / FCF TTM 4.91b)
FCF Yield = 5.05% (FCF TTM 4.91b / Enterprise Value 97.2b)
FCF Margin = 6.68% (FCF TTM 4.91b / Revenue TTM 73.6b)
Net Margin = -3.06% (Net Income TTM -2.25b / Revenue TTM 73.6b)
Gross Margin = 19.87% ((Revenue TTM 73.6b - Cost of Revenue TTM 58.9b) / Revenue TTM)
Gross Margin QoQ = 20.58% (prev 21.31%)
Tobins Q-Ratio = 0.97 (Enterprise Value 97.2b / Total Assets 100b)
Interest Expense / Debt = 0.85% (Interest Expense 413.9m / Debt 48.5b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -3.71b (EBIT -4.69b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.14 (Total Current Assets 60.4b / Total Current Liabilities 53.1b)
Debt / Equity = 1.71 (Debt 48.5b / totalStockholderEquity, last quarter 28.4b)
Debt / EBITDA = -6.66 (negative EBITDA) (Net Debt 11.4b / EBITDA -1.70b)
Debt / FCF = 2.31 (Net Debt 11.4b / FCF TTM 4.91b)
Total Stockholder Equity = 29.8b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.38% (Net Income -2.25b / Total Assets 100b)
RoE = -7.57% (Net Income TTM -2.25b / Total Stockholder Equity 29.8b)
RoCE = -12.10% (EBIT -4.69b / Capital Employed (Equity 29.8b + L.T.Debt 9.00b))
RoIC = -5.32% (negative operating profit) (NOPAT -3.71b / Invested Capital 69.7b)
WACC = 6.45% (E(85.8b)/V(134b) * Re(9.71%) + D(48.5b)/V(134b) * Rd(0.85%) * (1-Tc(0.21)))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -49.44 | Cagr: -45.46%
[DCF] Terminal Value 75.44% ; FCFF base≈4.91b ; Y1≈4.93b ; Y5≈5.22b
[DCF] Fair Price = 89.46 (EV 81.3b - Net Debt 11.4b = Equity 69.9b / Shares 781.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.49 | # QB: 0
Revenue Correlation: 98.62 | Revenue CAGR: 62.07% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.59 | Chg30d=+26.99% | Revisions=+33% | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.22 | Chg30d=+35.29% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=-1.75 | Chg30d=-893.75% | Revisions=-33% | GrowthEPS=-264.6% | GrowthRev=+20.4%
EPS next Year (2027-12-31): EPS=3.90 | Chg30d=-17.18% | Revisions=-43% | GrowthEPS=+322.9% | GrowthRev=+27.4%
[Analyst] Revisions Ratio: -43%